International Journal of Gynecology & Obstetrics
Volume 88, Issue 3 , Pages 292-298 , March 2005

Serum tumor necrosis factor alpha receptors p55/p75 ratio and ovarian cancer detection

  • P. Rzymski

      Affiliations

    • Department of Mother's and Child's Health, Karol-Marcinkowski University of Medical Sciences, Polna St 33, 60-535 Poznan, Poland
    • Corresponding Author InformationCorresponding author. Tel.: +48 605 393096; fax: +48 61 8419288.
    • ,
  • T. Opala

      Affiliations

    • Department of Mother's and Child's Health, Karol-Marcinkowski University of Medical Sciences, Polna St 33, 60-535 Poznan, Poland
    • ,
  • M. Wilczak

      Affiliations

    • Department of Educational Medicine, Karol-Marcinkowski University of Medical Sciences, Polna St 33, 60-535 Poznan, Poland
    • ,
  • J. Woźniak

      Affiliations

    • Department of Mother's and Child's Health, Karol-Marcinkowski University of Medical Sciences, Polna St 33, 60-535 Poznan, Poland
    • ,
  • S. Sajdak

      Affiliations

    • Department of Gynaecologic Surgery, Karol-Marcinkowski University of Medical Sciences, Polna St 33, 60-535 Poznan, Poland

Received 9 September 2004 ,Revised 9 December 2004 ,Accepted 22 December 2004.

References 

  1. Kost ER, Herzog TJ, Adler LM, Williams S, Mutch DG. The role of tumor necrosis factor receptors in tumor necrosis factor-α-mediated cytolysis of ovarian cancer cell lines. Am. J. Obstet. Gynecol. 1996;174:145–153
  2. Wu S, Boyer M, Whitaker RS, Berchuck A, Wiener JR, Wienberg JB, et al. Tumor necrosis factor α as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor α expression. Cancer Res. 1993;53:1939–1944
  3. Medvedev A, Espevik T, Ranges T, Saudan A. Distinct roles of two tumor necrosis factor (TNF) receptors in modultaing TNF and lymphotoxin α effects. J. Biol. Chem. 1996;271:9778–9784
  4. Bigda J, Beletsky I, Brakebush C, Varfolomeer Y, Engelman H, Bigda J, et al. Dual role of the p75 tumor necrosis factor (TNF) receptor in TNF cytotoxicity. J. Exp. Med. 1994;180:445–460
  5. Tartaglia AT, Pennica D, Goedddel DV. Ligand passing: the 75 kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J. Biol. Chem. 1993;268:18542–18548
  6. Bazzoni F, Beutler B. The tumor necrosis factor ligand and receptor families. N. Engl. J. Med. 1996;334:1717–1724
  7. Olsson I, Gatanga T, Bullberg U, Lautz M, Granger GA. Tumor necrosis factor (TNF) binding proteins (soluble TNF receptor forms) with possible roles in inflammation and malignancy. Eur. Cytokine Netw. 1993;4:169–180
  8. Gadducci A, Ferdeghini M, Castellani C, Annicchiarico C, Cagetti O, Prontera C, et al. Serum levels of tumor necrosis factor (TNF), soluble receptors for TNF (55- and 75-kDA sTNFr) and soluble CD14 (sCD14) in epithelial ovarian cancer. Gynecol. Oncol. 1995;58:184–188
  9. Naylor MS, Stamp GWH, Foulkes WD, Eccles D, Balkwill FR. Tumor necrosis factor and its receptors in human ovarian cancer—potential role in disease progression. J. Clin. Invest. 1993;91:2194–2206
  10. Onsrud M, Shabana A, Austgulen R, Nustad K. Comparison between soluble tumor necrosis factor receptors and CA125 in peritoneal fluids as a marker for epithelial ovarian cancer. Gynecol. Oncol. 1995;57:183–187
  11. Ferrazzi E, Zanetta G, Dordoni D, Berlanda N, Mezzopane R, Lissoni AA. Transvaginal ultrasonographic characterisation of ovarian masses: comparison of five scoring system in a multicenter study. Ultrasound Obstet. Gynecol. 1997;10:192–197
  12. Metz CE, Herman BA, Roe CA. Statistical comparison of two ROC curve estimates obtained from partially-paired datasets. Med. Decis. Mak. 1998;18:110–121
  13. Aslam N, Tailor A, Lawton F, Carr J, Savvash M, Jurkovic D. Prospective evaluation of three different models for the pre-operative diagnosis of ovarian cancer. BJOG. 2000;107:1347–1353
  14. Topalak O, Saygili U, Soyturk M, Karaca N, Batur Y, Uslu T, et al. Serum, pleural effusion and ascites CA125 levels in ovarian cancer and nonovarian benign and malignant disease: a comparative study. Gynecol. Oncol. 2002;85:108–113
  15. Menon U, Talaat A, Rosenthal AN, Macdonald ND, Jeyerajah AR, Skates SJ, et al. Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening. BJOG. 2002;107:165–169
  16. Berek JS, Bast RC. Ovarian cancer screening. Cancer. 1995;76:2092–2096
  17. Woolas RP, Oram DH, Jeyarajah AR, Bast RC, Jacobs IJ. Ovarian cancer identified through screening with serum markers but not by pelvic imaging. Int. J. Gynecol. Cancer. 1999;9:497–501
  18. Markowska J, Wilkoszarska J. The value of CA 125 levels in serum, peritoneal fluid and tumor in women with ovarian cancer. Ginekol. Pol. 1996;67:352–356
  19. Gotlieb WH, Soriano D, Achiron R, Zalel Y, Davidson B, Kopolovic J, et al. CA125 measurement and ultrasonography in borderline tumors of the ovary. Am. J. Obstet. Gynecol. 2000;183:.541–546
  20. Moradi MM, Carson LF, Weinberg B, Haney AF, Twiggs LB, Ramahrishnan S. Serum and ascitic fluid levels of interleukin-1, interleukin-6 and tumor necrosis factor-alpha in patients with ovarian epithelial cancer. Cancer. 1993;72:2433–2440
  21. Viac J, Vincent C, Palacio S, Schmitt D, Claudy A. Tumour necrosis factor (TNF) soluble receptors in malignant melanoma: correlation with soluble ICAM-1 levels. Eur. J. Cancer. 1996;32:447–449
  22. Hensler T, Sauerland S, Bouillon B, Raum M, Rixen D, Helling HJ, et al. Association between injury of patients with multiple injuries and circulating levels of soluble tumor necrosis factor receptors, interleukin-6 and interleukin-10 and polymophonuclear neutrophil elastase. J. Trauma. 2002;52:962–970
  23. Khoury SJ, Orav EJ, Guttmann CRG, Kikinis R, Jolesz FA, Weiner HL. Changes in serum levels of ICAM and TNF-R correlate with disease activity in multiple sclerosis. Neurology. 1999;53:758–764
  24. Grosen EA, Granger GA, Gatanga M, Ininis EK, Hwang C, DiSaia P, et al. Measurement of the soluble membrane receptors for tumor necrosis factor and lymphotoxin in the sera of patients with gynecologic malignancy. Gynecol. Oncol. 1993;50:68–77
  25. Al-Harthi L, Wright DJ, Anderson D, Cohen M, Matity Ahu D, Cohn J, et al. The impact of the ovulatory cycle on cytokine production: evaluation of systemic, cervicovaginal and salivary compartments. J. Interferon Cytokine Res. 2000;20:719–724

PII: S0020-7292(05)00024-X

doi: 10.1016/j.ijgo.2004.12.015

International Journal of Gynecology & Obstetrics
Volume 88, Issue 3 , Pages 292-298 , March 2005

Article Tools

* Image Usage & Resolution